# Olema Pharmaceuticals, Inc.: Form SC 13D/A, filed Jun 6, 2024

- Company: [Olema Pharmaceuticals, Inc.](/companies/olma.md) (CIK 1750284)
- Form: SC 13D/A
- Filed: 2024-06-06
- Accepted by EDGAR: Jun 6, 2024, 18:49 ET
- Period: not reported
- Accession: 0000935836-24-000426
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1750284/000093583624000426/olma13ga2.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750284/000093583624000426/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750284/000093583624000426/olma13ga2.htm

Filed Jun 6, 2024.
Source: SEC EDGAR, the filing index for accession 0000935836-24-000426. Last ingested by Listed: Nov 10, 2026, 16:50 ET. No prices; not investment advice.
